Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4551
Ramaco Resources Class B
METCB
$336M
| $2.85M | ﹤0.01% |
341,598
+9,323
| +3% | +$94.3K |
|
|
NFGC
4552
New Found Gold
NFGC
$665M
| $2.84M | ﹤0.01% |
1,847,247
-811,360
| -31% | -$1.56M |
|
4553
Sprott Junior Gold Miners ETF
SGDJ
$342M
| $2.84M | ﹤0.01% |
37,659
+16,073
| +74% | +$1.41M |
|
|
BCYC
4554
Bicycle Therapeutics
BCYC
$255M
| $2.83M | ﹤0.01% |
667,269
+48,942
| +8% | +$224K |
|
4555
Virgin Galactic
SPCE
$444M
| $2.83M | ﹤0.01% |
978,276
+327,380
| +50% | +$1.07M |
|
4556
United States Natural Gas Fund
UNG
$569M
| $2.82M | ﹤0.01% |
240,947
+41,969
| +21% | +$469K |
|
4557
Fidelity High Yield Factor ETF
FDHY
$612M
| $2.82M | ﹤0.01% |
57,559
-7,590
| -12% | -$373K |
|
4558
Franklin Covey
FC
$201M
| $2.82M | ﹤0.01% |
115,046
+2,629
| +2% | +$59.9K |
|
4559
VanEck India Growth Leaders ETF
GLIN
$88.3M
| $2.82M | ﹤0.01% |
60,683
-156,848
| -72% | -$7.07M |
|
|
DFP
4560
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$401M
| $2.82M | ﹤0.01% |
136,282
+17,684
| +15% | +$365K |
|
4561
VanEck Retail ETF
RTH
$238M
| $2.81M | ﹤0.01% |
10,994
+2,779
| +34% | +$727K |
|
4562
Information Services Group
III
$255M
| $2.81M | ﹤0.01% |
684,178
-6,364
| -0.9% | -$26.6K |
|
|
TTAM
4563
Titan America SA
TTAM
$2.55B
| $2.81M | ﹤0.01% |
150,477
-17,195
| -10% | -$283K |
|
4564
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
$461M
| $2.81M | ﹤0.01% |
72,202
-1,169
| -2% | -$46.4K |
|
|
WLTH
4565
Wealthfront Corp
WLTH
$1.59B
| $2.8M | ﹤0.01% |
312,853
+79,094
| +34% | +$824K |
|
4566
Primis Financial Corp
FRST
$391M
| $2.78M | ﹤0.01% |
170,097
+5,781
| +4% | +$84.3K |
|
|
HPF
4567
John Hancock Preferred Income Fund II
HPF
$311M
| $2.78M | ﹤0.01% |
175,326
-842
| -0.5% | -$13.4K |
|
|
SRV
4568
NXG Cushing Midstream Energy Fund
SRV
$272M
| $2.78M | ﹤0.01% |
55,520
+4,418
| +9% | +$209K |
|
4569
South Plains Financial
SPFI
$822M
| $2.77M | ﹤0.01% |
64,273
-769
| -1% | -$32.1K |
|
|
JBIO
4570
Jade Biosciences
JBIO
$1.06B
| $2.77M | ﹤0.01% |
124,513
+73,918
| +146% | +$1.54M |
|
4571
iShares Genomics Immunology and Healthcare ETF
IDNA
$257M
| $2.75M | ﹤0.01% |
81,337
-12,874
| -14% | -$386K |
|
|
CMDB
4572
Costamare Bulkers Holdings
CMDB
$570M
| $2.75M | ﹤0.01% |
156,325
-2,525
| -2% | -$43.9K |
|
4573
Aquestive Therapeutics
AQST
$605M
| $2.74M | ﹤0.01% |
658,617
-933,175
| -59% | -$3.93M |
|
4574
WisdomTree International MidCap Dividend Fund
DIM
$163M
| $2.74M | ﹤0.01% |
32,139
+160
| +0.5% | +$13.9K |
|
4575
Verastem
VSTM
$663M
| $2.73M | ﹤0.01% |
715,822
-1,531,451
| -68% | -$7.41M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.